Invest Million Team

Invest Million Team

336 posts
Biogen Inc. (BIIB)

Biogen (NASDAQ: BIIB) And Sage Therapeutics Inks Agreement To Develop Therapies For Depression

Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) communicated that they are partnering together and will be combining their efforts to develop and commercialize SAGE-324 for neurological disorders like tremors and SAGE-217 i.e. Zuranolone for Postpartum Depression (PPD), Major Depressive Disorders